Ethnic variation of the P53 codon 72 polymorphism, HPV persistence, and cervical cancer risk

International Journal of STD and AIDS

Volumn 14, Issue 12, 2003, Pages 800-804

  Inserra, P ^a   Abrahamsen, M ^a   Papenfuss, M ^a   Giuliano, A R ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Cervical cancer; HPV; p53 codon 72; Polymorphism

Indexed keywords

ARGININE; PRIMER DNA; PROTEIN P53;

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; AMERICAN INDIAN; ARTICLE; ASIAN AMERICAN; CANCER RISK; CAUCASIAN; CODON; CONTROLLED STUDY; CYTOLOGY; DNA HYBRIDIZATION; DNA POLYMORPHISM; ETHNIC DIFFERENCE; ETHNOLOGY; FEMALE; GENE AMPLIFICATION; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; UTERINE CERVIX CANCER; VIRUS DETECTION; WART VIRUS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CODON; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 0346723043     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646203322556110     Document Type: Article

References (34)

1. Storey A, Thomas M, Kalita A, et al. Role of p53 polymorphism in the development of human papillomavirus associated cancer. Nature 1998;393:229-34
2. Zehbe I, Voglino G, Wilander E, et al. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development. Cancer Res 2001;61:608-11
3. Makni H, Franco EL, Kalano J, et al. p53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation. Int J Cancer 2000;87:528-33
4. Agorastos T, Lambropoulos AF, Constantinidis TC, Kotsis A, Bontis JN. p53 codon 72 polymorphism and risk of intraepithelial and invasive cervical neoplasia in Greek women. Eur J Cancer Prev 2000;9:113-18
5. Zehbe I, Voglino G, Wilander E, Genta F, Tommasino M. Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet 1999;354:218-19
6. Gustafsson AC, Guo Z, Hu X, et al. HPV-related cancer susceptibility and p53 codon 72 polymorphism. Acta Derm Venereol 2001;81:125-9
7. Giannoudis A, Graham DA, Southern SA, Herrington CS. p53 codon 72 ARG/ PRO polymorphism is not related to HPV type or lesion grade in low and high grade squamous intra-epithelial lesions and invasive squamous carcinoma of the cervix. Int J Cancer 1999;83:66-9
8. Nishikawa A, Fujimoto T, Akutagawa N, et al. p53 Polymorphism (codon-72) has no correlation with the development and the clinical features of cervical cancer. Int J Gynecol Cancer 2000;10:402-7
9. Kim JW, Roh JW, Park NH, Song YS, Kang SB, Lee HP. Polymorphism of TP53 codon 72 and the risk of cervical cancer among Korsean women. Am J Obstet Gynecol 2001; 184:55-8
10. Kucera E, Tong D, Reinthaller A, Leodolter S, Zeillinger R, Sliutz G. p53 polymorphism at codon 72 - does it constitute a risk for squamous intraepithelial lesions and invasive cancer of the cervix in Central Europeans. Wien Klin Wochenschr 2000;112:817-20
11. Pegoraro R, Moodley J, Naiker S, Lanning P, Rom L. The p53 codon 72 polymorphism in black South African women and the risk of cervical cancer. Br J Obstet Gynaecol 2000;107:1164-5
12. Wong YF, Chung TK, Cheung TH, et al. p53 polymorphism and human papillomavirus infection in Hong Kong women with cervical cancer. Gynecol Obstet Invest 2000;50:60-3
13. Tenti P, Vesentini N, Rondo Spaudo M, et al. p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy. Cancer Epi Biomark Prev 2000;9:435-8
14. Baek WK, Cho JW, Suh SL, et al. p53 codon 72 polymorphism and risk of cervical carcinoma in Korean women. J Korean Med Sci 2000;15:65-7
15. Tachezy R, Mikyskova I, Salakova M, van Ranst M. Correlation between human papillomavirus-associated cervical cancer and p53 codon 72 arginine/proline polymorphism. Hum Genet 1999;105:564-6
16. Szarka K, Veress G, Konya J, Gergely L. Frequency of p53 codon 72 genotypes in human papillomavirus associated squamous intraepithelial lesions and cervical cancer. Anticancer Res 1999;19:2377-9
17. Yamashita T, Yaginuma Y, Saitoh Y, et al. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix. Carcinogenesis 1999;20:1733-6
18. Ngan HY, Liu VW, Liu SS. Risk of cervical cancer is not increased in Chinese carrying homozygous arginine at codon 72 of p53. Br J Cancer 1999;80:1828-9
19. Wang NM, Tsai CH, Yeh KT, Chen SJ, Chang JG. p53 codon 72Arg polymorphism is not a risk factor for carcinogenesis in the Chinese. Int J Mol Med 1999;4:249-52
20. Klaes R, Ridder R, Schaefer U, Benner A, von Knebel Doeberitz M. No evidence of p53 allele-specific predisposition in human papillomavirus- associated cervical cancer. J Mol Med 1999;77:299-302
21. Minaguchi T, Kanamori Y, Matsushima M, Yoshikawa H, Taketani Y, Nakamura Y. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res 1998;58:4585-6
22. Rosenthal AN, Ryan A, Al-Jehani RM, Storey A, Harwood CA, Jacobs IJ. p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet 1998;352:871-2
23. Klug SJ, Wilmotte R, Santos C, et al. Tp53 polymorphism, HPV infection, and risk of cervical cancer. Cancer Epi Biomark Prev 2001;10:1009-112
24. Dokianakis DN, Spandidos DA. p53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer. Mol Cell Biol Res Commun 2000;3:111-14
25. Giuliano AR, Papenfuss M, Schneider A, Nour MA, Hatch K. Risk factors for high risk type human papillomavirus (HPV) infection among Mexican American women. Cancer Epi Biomark Prev 1999;8:615-20
26. Giuliano AR, Denman C, de Zapien J, et al. Design and results of the USA-Mexico border human papillomavirus (HPV), cervical dysplasia, and Chlamydia trachomatis study. Rev Panam Salud Publica 2001;9:172-81
27. Giuliano AR, Harris R, Sedjo RL, et al. Incidence, prevalence, and clearance of type-specific HPV infections: The Young Women's Health Study. J Infect Dis (accepted for publication)
28. Wright DK, Manos MM. Sample preparation from paraffin-embedded tissue. In Innes M, Gelford D, Sninsky J, White T, eds. PCR protocols: a guide to methods and applications. San Diego, CA: Academic Press, 1990:153-8
29. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000;38:357-61
30. Giuliano AR, Harris R, Sedjo RL, et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the young women's health study. J Infect Dis 2002;186:462-9
31. Ara S, Lee PSY, Hansen MF, Saya H. Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res 1990;18:4961
32. De la Calle-Martin O, Fabregat V, Romero M, Soler J, Vives J, Yague J. Accll polymorphism of the p53 gene. Nucleic Acids Res 1990;18:4963
33. Sjalander A, Birgander R, Saha N, Beckman L, Beckman G. p53 polymorphism and haplotypes show distinct differences between major ethnic groups. Hum Hered 1996;46:41-8
34. Ho GY, Bierman R, Beardsley L, Cheng CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8